Veracyte (VCYT) Capital Expenditures Growth (1y) (2013 - 2026)
Veracyte (VCYT) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 27.78% |
| 10 | Veracyte | 3.68 Bn | 3.38 Bn | 108.55 Mn | 122.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.32% |
| Mar 31, 2026 | -92.74% |
| Dec 31, 2025 | 77.16% |
| Sep 30, 2025 | -138.38% |
| Jun 30, 2025 | 239.63% |
| Mar 31, 2025 | -14.76% |
| Dec 31, 2024 | -162.12% |
| Sep 30, 2024 | 1,050.80% |
| Jun 30, 2024 | -59.90% |
| Mar 31, 2024 | 31.40% |
| Dec 31, 2023 | 214.34% |
| Sep 30, 2023 | -308.70% |
| Jun 30, 2023 | 7.99% |
| Mar 31, 2023 | 374.85% |
| Dec 31, 2022 | 173.23% |
| Sep 30, 2022 | -93.36% |
| Jun 30, 2022 | 46.31% |
| Mar 31, 2022 | -71.40% |
| Dec 31, 2021 | -4,371.13% |
| Sep 30, 2021 | 411.12% |